SAFE vs. Convertible Note: Which Is Right for Your Raise?

San Francisco financial district. Photo: Stephen Leonardi via Pexels.

Early-stage founders face a chicken-and-egg problem: investors want to fund the company, but nobody wants to fight over a valuation before there is enough traction to justify one. Two instruments solve this by letting you raise now and price the equity later — the SAFE and the convertible note. They look similar on the surface, but the differences show up at the moment that matters most: when the money converts and you see how much of your company you actually gave away.

The Core Idea: Raise Now, Price Later

Both a SAFE (Simple Agreement for Future Equity) and a convertible note let an investor contribute capital today in exchange for the right to receive equity later — typically when the company closes a priced equity financing. Neither requires the founder and investor to agree on a company valuation at the time of investment. Instead, the investment converts into shares in a future financing, usually on terms more favorable to the early investor than the new money in that round. That favorable treatment is the reward for taking early-stage risk before the company has a proven valuation.

But neither instrument avoids securities-law compliance. SAFEs and convertible notes are securities, and a startup generally needs to rely on an exemption from registration, comply with applicable federal and state securities rules, confirm investor eligibility where required, and make any required filings — such as a Form D for certain Regulation D offerings. The apparent simplicity of the paperwork does not turn a fundraise into a private contract free of regulatory obligations.

The fundamental difference is what each instrument is designed to be. A convertible note is debt — a loan, with an interest rate and a maturity date, intended to convert into equity rather than be repaid in cash. A standard SAFE is generally not structured as debt — it is a contractual right to receive future equity if a triggering event occurs, typically with no interest and no maturity date. That distinction affects whether a deadline exists, whether interest accrues, what rights the investor has if the company winds down, and how the instrument may be reflected for accounting purposes.

The SAFE in Depth

The SAFE was introduced by Y Combinator in 2013 as a deliberately simple alternative to the convertible note, and it is often described as founder-friendly because it removes interest, maturity, and debt mechanics. But the economics still matter, especially under the post-money SAFE — "simple" does not always mean "in the founder’s favor."

Because a standard SAFE is not a loan, it typically has no maturity date. There is no scheduled due date, no repayment obligation merely because time has passed, and no default simply because a priced round took longer than expected. It also carries no interest, so the amount that converts is generally based on the original investment amount, adjusted by the valuation cap, discount, or other conversion terms. For a young company that wants to avoid debt pressure and move quickly, this simplicity is the central appeal.

A critical wrinkle: in 2018, Y Combinator moved from the original pre-money SAFE to the post-money SAFE, and the two calculate ownership very differently. Under the post-money SAFE, the investor’s ownership percentage is calculated on a post-money basis — after the SAFE money is accounted for, but before the new money in the priced equity round. This gives SAFE investors much more ownership certainty and generally shifts dilution from additional SAFEs onto the founders and existing stockholders rather than onto earlier SAFE investors. If you are raising on SAFEs, knowing whether you are using a pre-money or post-money SAFE is not optional.

The Convertible Note in Depth

The convertible note predates the SAFE and remains widely used. At its heart it is a loan: the investor lends the company money, the loan accrues interest, and it has a maturity date by which it must convert, be repaid, be extended, or otherwise be addressed. What makes it "convertible" is that the parties usually intend for it to turn into equity at a future financing rather than be repaid in cash.

Two features distinguish it sharply from a SAFE. First, the interest rate — typically a modest percentage that accrues over the life of the note and, in many deals, converts into additional equity at the priced round rather than being paid out. Over a year or two, accrued interest can meaningfully increase the number of shares the investor ultimately receives. Second, the maturity date — the deadline by which the note must convert or come due. If a qualifying priced round happens before maturity, the note may convert smoothly. If it does not, the company and investor must deal with the note through repayment of principal plus interest (often impractical for an early-stage company), extension, a negotiated conversion at a pre-agreed valuation, or amendment.

That maturity date is a double-edged feature. For investors, it provides leverage and a measure of protection — the note cannot drift indefinitely. For founders, it introduces real risk: a note that comes due in a slow fundraising environment can put an otherwise healthy company under pressure or into default. Because a note is debt, the investor generally sits ahead of equity holders in a wind-down, subject to any subordination, secured creditor rights, the note’s actual terms, and applicable law. That usually gives a noteholder a stronger downside position than a SAFE holder.

Key Terms You Need to Understand

Whichever instrument you choose, a handful of terms determine the actual economics. These are where negotiation happens and where founders most often give up value without realizing it.

• Valuation cap — the maximum company valuation at which the investment converts into equity. A lower cap means the early investor’s money buys a larger slice of the company. This is usually the single most heavily negotiated term.
• Discount rate — a percentage reduction (commonly 10–25%) off the price per share that priced-round investors pay. When an instrument has both a cap and a discount, it typically converts using whichever produces the better result for the investor.
• Maturity date (notes only) — the date a convertible note comes due. Its presence creates a deadline; its absence in a standard SAFE removes one.
• Interest rate (notes only) — accrues over the life of a note and usually converts into additional equity rather than cash. Note interest is often simple, not compounding, unless the note says otherwise — but accrued interest still increases the investor’s eventual share count.
• MFN ("most favored nation") — a clause letting an early investor claim the better terms of any instrument you later issue on more favorable conditions. It can quietly upgrade the whole stack to your most generous terms.
• Qualified financing threshold — the size of priced round that automatically triggers conversion. Set it carelessly and a small round might not trip the trigger, leaving instruments outstanding and creating uncertainty about the cap table before the next raise.
• Pro rata rights — the right of an early investor to invest again in future rounds to maintain their ownership percentage. Worth understanding before you grant them broadly.

The Dilution Math Founders Underestimate

The most expensive mistakes happen not in any single deal but in how multiple instruments interact. Founders tend to evaluate each SAFE or note in isolation — "this one’s a fair cap" — without modeling what happens when all of them convert at the same priced round, simultaneously, alongside a new investor’s money and a freshly expanded option pool.

Consider a founder who raises on several SAFEs over eighteen months, each at a slightly different cap as the company gains traction. Individually, every cap looked reasonable. But at the priced round, all of those SAFEs convert at once, each at its own cap, and the combined ownership can be dramatically larger than the founder pictured. Under post-money SAFEs in particular, that dilution lands on the founders and existing stockholders rather than the earlier SAFE investors. Layer in a new lead investor’s stake and a 10–15% option pool that investors often require be created before their money goes in, and the founder’s post-round ownership can land well below what back-of-the-envelope math suggested.

This is why building and maintaining a cap table model is essential before signing any instrument. The model should show how each SAFE or note converts under realistic priced-round scenarios, how the option pool expansion hits existing holders, and what the founder’s ownership looks like on the other side. Signing convertible instruments without that model is the most common way founders end up giving away more of their company than they ever intended — and by the priced round, it is too late to fix.

When a SAFE Makes Sense

• Pre-seed and seed rounds where speed and simplicity carry the day.
• You want to keep debt off the company’s books — no maturity date typically means no looming repayment obligation and no default risk.
• You’re raising from investors fluent in startup norms — SAFEs are standard across much of the venture ecosystem.
• You want lower legal and negotiation costs — standardized SAFE forms execute quickly.
• You expect a priced round on an uncertain timeline — without a maturity date, a longer runway creates no contractual pressure.

When a Convertible Note Makes Sense

• Investors want downside protection — as debt, the note generally sits ahead of equity if the company winds down.
• You need a built-in deadline — the maturity date creates pressure to reach a priced round.
• Your investors expect a return that accrues — some prefer the interest a note provides.
• The raise is a bridge — notes are common for short-term financing between priced rounds.
• You’re dealing with more traditional or angel investors — some are simply more comfortable with the familiar mechanics of a loan.

Securities Compliance and State "Blue Sky" Rules

Startup fundraising is not just a document-choice issue. Whether you use a SAFE, a convertible note, or a priced round, the offering may need to comply with federal securities exemptions and applicable state "blue sky" rules in the states where investors reside. For founders raising in Arizona, California, or Texas, that compliance analysis should happen before checks are accepted — confirming the available exemption, verifying investor eligibility where required, and making any required filings.

It is also worth noting that the instrument you sign and the state where your business is formed can be two different questions. Many startups incorporate in Delaware for entity-law reasons while operating and raising from investors in AZ, CA, or TX. That split means your securities and blue-sky analysis follows where your investors are, even if your certificate of incorporation lives elsewhere.

How a Business Attorney Helps

A SAFE and a convertible note are both legitimate ways to raise capital without locking in a valuation before your company is ready for one. But "standard" forms still carry terms — caps, discounts, maturity dates, MFN provisions, conversion thresholds — that meaningfully shift how much of your company you keep on the other side of your next round. Before you sign, it is worth modeling the conversion and having an attorney review the specific terms and the securities-law path against your goals. Licensed in Arizona, California, and Texas, our corporate formation and contracts practices help founders and investors structure raises that are clear, compliant, and aligned with what they are building.

Frequently Asked Questions

This article is for general informational purposes only and is not legal, tax, accounting, or investment advice. Startup financing documents should be reviewed in light of the company’s entity structure, investor base, securities-law exemption, tax considerations, and fundraising plan. Reading this article does not create an attorney-client relationship. For guidance on your specific situation, please consult a qualified attorney.